Harvest Management LLC boosted its stake in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) by 50.7% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 157,600 shares of the biopharmaceutical company’s stock after buying an additional 53,000 shares during the quarter. Horizon […]
Farallon Capital Management LLC boosted its holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) by 46.7% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,419,823 shares of the biopharmaceutical company’s stock after acquiring an additional 1,724,900 shares during the quarter. Horizon […]
StockNews.com cut shares of Horizon Therapeutics Public (NASDAQ:HZNP – Free Report) from a strong-buy rating to a buy rating in a report released on Tuesday morning. A number of other research firms also recently weighed in on HZNP. TheStreet downgraded shares of Horizon Therapeutics Public from a b- rating to a c+ rating in a […]
Gabelli Funds LLC grew its stake in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) by 108.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 463,294 shares of the biopharmaceutical company’s stock after acquiring an additional 241,294 shares during the […]
Renaissance Technologies LLC raised its position in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) by 101.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,368,449 shares of the biopharmaceutical company’s stock after acquiring an additional 1,693,400 shares during the quarter. Horizon […]